Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80 count bottles (NDC 69842-871-80) c.)160 count bottles (NDC 69842-871-37) (CVS) OTC
Dr. Reddy's Laboratories
CGMP Deviations: Presence of NDMA impurity detected in product.
95,038 total recalls in our database
Dr. Reddy's Laboratories
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Particulate Matter.
First Royal Care Co. LLC
Lack of Assurance of Sterility
First Royal Care Co. LLC
Lack of Assurance of Sterility
Marketed without an Approved NDA/ANDA
First Royal Care Co. LLC
Lack of Assurance of Sterility
First Royal Care Co. LLC
Lack of Assurance of Sterility
Marketed without an Approved NDA/ANDA
First Royal Care Co. LLC
Lack of Assurance of Sterility
First Royal Care Co. LLC
Lack of Assurance of Sterility
First Royal Care Co. LLC
Lack of Assurance of Sterility
The seal formed on the edge of the pouch may be incomplete, which could result in a loss of sterility to the product.
Non-highly polished implants may adhere to the LDPE bag (previous packaging configuration).
Zimmer Biomet
Non-highly polished implants may adhere to the LDPE bag (previous packaging configuration).
Life Technologies
Component was not tested by the supplier for adventitious agents
The assigned value for Rheumatoid Factor over recovers against the reference material RF serum, 1st British standard from NIBSC. Ref = 64/002. The calibrator values have been adjusted to re-align to the reference material.
Baxter Healthcare
Communication error alarms may result in interruption of therapy, delay in therapy, or blood loss due to non-restitution of blood in the extracorporeal circuit.
Non-highly polished implants may adhere to the LDPE bag (previous packaging configuration).
Baxter Healthcare
Communication error alarms may result in interruption of therapy, delay in therapy, or blood loss due to non-restitution of blood in the extracorporeal circuit.
Non-highly polished implants may adhere to the LDPE bag (previous packaging configuration).